Prospective Data Collection of Patients With Diffuse Parenchymal Lung Diseases

This study is currently recruiting participants.
Verified May 2012 by Singapore General Hospital
Sponsor:
Information provided by (Responsible Party):
Singapore General Hospital
ClinicalTrials.gov Identifier:
NCT01600378
First received: May 15, 2012
Last updated: May 16, 2012
Last verified: May 2012
  Purpose

The purpose of this study is to generate a prospective database of all patients evaluated for diffuse parenchymal lung diseases to provide much needed data on the various disease aetiologies, incidence and prevalence rates, clinical and radiological presentations, pathologic correlations, disease progression and response to treatment, and final outcomes in this group of patients in Singapore.


Condition
Diffuse Parenchymal Lung Diseases

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Prospective Data Collection of Clinical, Pulmonary Function, Radiological, Bronchoscopic and Fibered Confocal Fluorescence Microscopy Imaging, and Pathological Characteristics in Patients With Diffuse Parenchymal Lung Diseases

Resource links provided by NLM:


Further study details as provided by Singapore General Hospital:

Estimated Enrollment: 500
Study Start Date: May 2012
Estimated Study Completion Date: April 2022
Estimated Primary Completion Date: April 2022 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   21 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients evaluated for diffuse parenchymal lung diseases

Criteria

Inclusion Criteria:

  • All patients 21 years old and older diagnosed with suspected diffuse parenchymal lung disease (multi-lobar pulmonary infiltrates)

Exclusion Criteria:

  • None
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01600378

Contacts
Contact: Su Ying Low, BMBCh +65 63214700 low.su.ying@sgh.com.sg

Locations
Singapore
Singapore General Hospital Recruiting
Singapore, Singapore, 169608
Contact: Su Ying Low, BMBCh    +65 3214700    low.su.ying@sgh.com.sg   
Principal Investigator: Su Ying Low, BMBCh         
Sponsors and Collaborators
Singapore General Hospital
Investigators
Principal Investigator: Su Ying Low, BMBCh Singapore General Hospital
  More Information

Publications:
Responsible Party: Singapore General Hospital
ClinicalTrials.gov Identifier: NCT01600378     History of Changes
Other Study ID Numbers: 2012/245/Cilddatabase
Study First Received: May 15, 2012
Last Updated: May 16, 2012
Health Authority: Singapore: Domain Specific Review Boards

Keywords provided by Singapore General Hospital:
diffuse parenchymal lung disease
interstitial lung disease
idiopathic pulmonary fibrosis

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Interstitial
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on April 17, 2014